Lord, Abbett & Co’s Coherus Oncology, Inc. Common Stock CHRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q1 | – | Sell |
-143,360
| Closed | -$2.49M | – | 647 |
|
|
2020
Q4 | $2.49M | Sell |
143,360
-707,125
| -83% | -$12.3M | 0.01% | 625 |
|
|
2020
Q3 | $15.6M | Buy |
850,485
+33,717
| +4% | +$618K | 0.05% | 413 |
|
|
2020
Q2 | $14.6M | Sell |
816,768
-125,013
| -13% | -$2.23M | 0.05% | 418 |
|
|
2020
Q1 | $15.3M | Sell |
941,781
-2,130,459
| -69% | -$34.6M | 0.07% | 362 |
|
|
2019
Q4 | $55.3M | Buy |
3,072,240
+166,776
| +6% | +$3M | 0.18% | 164 |
|
|
2019
Q3 | $58.9M | Buy |
2,905,464
+491,126
| +20% | +$9.95M | 0.2% | 153 |
|
|
2019
Q2 | $53.4M | Buy |
+2,414,338
| New | +$53.4M | 0.17% | 205 |
|
|
2017
Q3 | – | Sell |
-225,592
| Closed | -$3.24M | – | 867 |
|
|
2017
Q2 | $3.24M | Sell |
225,592
-3,800
| -2% | -$54.5K | 0.01% | 823 |
|
|
2017
Q1 | $4.85M | Sell |
229,392
-33,162
| -13% | -$701K | 0.01% | 753 |
|
|
2016
Q4 | $7.39M | Sell |
262,554
-101,180
| -28% | -$2.85M | 0.02% | 645 |
|
|
2016
Q3 | $9.74M | Buy |
363,734
+95,161
| +35% | +$2.55M | 0.03% | 591 |
|
|
2016
Q2 | $4.54M | Buy |
268,573
+99,364
| +59% | +$1.68M | 0.01% | 732 |
|
|
2016
Q1 | $3.59M | Sell |
169,209
-13,320
| -7% | -$283K | 0.01% | 764 |
|
|
2015
Q4 | $4.19M | Sell |
182,529
-80,213
| -31% | -$1.84M | 0.01% | 769 |
|
|
2015
Q3 | $5.27M | Sell |
262,742
-107,203
| -29% | -$2.15M | 0.02% | 725 |
|
|
2015
Q2 | $10.7M | Buy |
+369,945
| New | +$10.7M | 0.03% | 628 |
|